Back to Screener

Healthcare

BioMarin Pharmaceutical Inc.(BMRN)

Live Price

Offline

$57.35

+0.03% today

Window Change

-4.54%

Window

May 29, 2026 โ†’ Jun 18, 2026

Market Cap
$10.24B
Revenue Growth
+12.9%
EPS Growth
-19.1%
Dividend Yield
0.0%
Sparse coverage

Historical coverage is still filling in

This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.

Coverage: 15 bars ยท May 29, 2026 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

BioMarin Pharmaceutical Inc. (BMRN) is a Healthcare stock with a market cap of $10.24B. The stock last traded around $57.35 and down 4.5% across the available one-year price window (May 29, 2026 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of +12.9%, EPS growth of -19.1%, a dividend yield of 0.0%. What stands out right now is revenue +12.9%, EPS -19.1%, free cash flow +52.5% with operating margin 13.8% and ROIC 4.0%. Valuation already assumes a fairly strong business story at P/E 38.1 and price/sales 3.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines BMRN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

BMRN vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

BMRN

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

BMRN Max Drawdown

-6.93%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for BMRN and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 7, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 7, 26
โ€”
Est 0.74
โ€”
โ€”
Est 756643.8B
โ€”
May 7
โ€”
Feb 23, 26
โœ—
-0.24
Est 0.17
-241.7%
874565.0B
Est 833732.1B
+4.9%
Feb 23
โ€”
Oct 27, 25
โœ“
0.12
Est -0.15
+180.0%
776133.0B
Est 823457.1B
-5.8%
Oct 27
โ€”
Aug 4, 25
โœ“
1.44
Est 0.86
+67.3%
825410.0B
Est 761947.2B
+8.3%
Aug 4
โ€”
May 1, 25
โœ“
1.13
Est 0.94
+20.2%
745145.0B
Est 762438.3B
-2.3%
May 1
โ€”
Feb 19, 25
โœ“
0.92
Est 0.54
+70.4%
738222.0B
Est 712298.3B
+3.6%
Feb 19
โ€”
Oct 29, 24
โœ“
0.91
Est 0.78
+16.7%
745740.0B
Est 712349.8B
+4.7%
Oct 29
โ€”
Aug 5, 24
โœ“
0.96
Est 0.36
+168.3%
708658.0B
Est 663978.2B
+6.7%
Aug 5
โ€”
Apr 24, 24
โœ“
0.71
Est 0.31
+127.7%
648833.0B
Est 651825.4B
-0.5%
Apr 24
โ€”
Feb 22, 24
โœ“
0.49
Est 0.44
+11.4%
646207.0B
Est 636670.0B
+1.5%
Feb 22
โ€”
Nov 1, 23
โ€”
0.46
Est 0.46
0.0%
585965.0B
Est 636240.0B
-7.9%
Nov 1
โ€”
Jul 31, 23
โœ“
0.54
Est 0.47
+14.9%
594598.0B
Est 595230.0B
-0.1%
Jul 31
โ€”
Apr 26, 23
โœ“
0.60
Est 0.43
+39.5%
592945.0B
Est 598860.0B
-1.0%
Apr 26
โ€”
Feb 27, 23
โœ“
0.36
Est -0.07
+614.3%
537538.0B
Est 537619.1B
-0.0%
Feb 27
โ€”
Oct 26, 22
โœ“
0.45
Est 0.37
+21.6%
505344.0B
Est 518452.6B
-2.5%
Oct 26
โ€”
Aug 3, 22
โœ“
0.59
Est 0.43
+37.2%
533798.0B
Est 520197.0B
+2.6%
Aug 3
โ€”
Apr 27, 22
โœ“
0.55
Est 0.38
+44.7%
519359.0B
Est 510954.5B
+1.6%
Apr 27
โ€”
Feb 23, 22
โœ“
0.03
Est 0.03
+0.4%
449810.0B
Est 442382.9B
+1.7%
Feb 23
โ€”
Oct 27, 21
โœ“
0.18
Est 0.11
+63.6%
408742.0B
Est 436530.0B
-6.4%
Oct 27
โ€”
Jul 28, 21
โœ“
0.53
Est 0.30
+76.7%
501693.0B
Est 437060.0B
+14.8%
Jul 28
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.